Amedica sets IPO terms, looks to raise $80.2M for implants
Amedica, a Salt Lake City device maker focused on spine, knee and hip implants, set its IPO terms and now hopes to raise as much as $80.2 million. The company plans to sell up to 5.3 million shares at a price of $13 to $15 apiece.
You can find our previous coverage of Amedica here and here. The company is notable in part because it listed the threat of government healthcare reform as a “risk factor” to its business in its SEC filing. It expects to launch its first spinal-implant products next year.
Next Story: Ouroboros raises $1.2M for spinal devices
Previous Story: Venture capitalists turn drug developers
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.